
Robert G. Bachner
Examiner (ID: 683, Phone: (571)270-3888 , Office: P/2898 )
| Most Active Art Unit | 2898 |
| Art Unit(s) | 2813, 2898 |
| Total Applications | 1255 |
| Issued Applications | 1079 |
| Pending Applications | 94 |
| Abandoned Applications | 114 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374347
[patent_doc_number] => 20230149426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => Nutritional Intervention for Improving Muscular Function and Strength
[patent_app_type] => utility
[patent_app_number] => 18/095314
[patent_app_country] => US
[patent_app_date] => 2023-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18095314
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/095314 | Nutritional Intervention for Improving Muscular Function and Strength | Jan 9, 2023 | Pending |
Array
(
[id] => 18434303
[patent_doc_number] => 20230181597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METAL COMPLEXES OF NOCARDAMINE AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/087564
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18087564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/087564 | METAL COMPLEXES OF NOCARDAMINE AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | Dec 21, 2022 | Pending |
Array
(
[id] => 18434221
[patent_doc_number] => 20230181515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => TREATMENT AND PREVENTION OF INFECTIONS USING VEGETABLE OIL-DERIVED POLYOLS
[patent_app_type] => utility
[patent_app_number] => 18/078414
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078414
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078414 | Treatment and prevention of infections using vegetable oil-derived polyols | Dec 8, 2022 | Issued |
Array
(
[id] => 20231270
[patent_doc_number] => 20250288589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => PYRIDOPYRIMIDINES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/717167
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18717167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/717167 | PYRIDOPYRIMIDINES AND METHODS OF THEIR USE | Dec 7, 2022 | Pending |
Array
(
[id] => 18391218
[patent_doc_number] => 20230159436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/056265
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056265
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056265 | APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES | Nov 16, 2022 | Abandoned |
Array
(
[id] => 19682337
[patent_doc_number] => 20250000882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST
[patent_app_type] => utility
[patent_app_number] => 18/706490
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706490 | LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST | Nov 3, 2022 | Pending |
Array
(
[id] => 19682274
[patent_doc_number] => 20250000819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => Anti-hypoxic/anoxic injury use of a magnolol and/or honokiol aromatic ring amino-substituted derivative, and a pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 18/693036
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18693036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/693036 | Anti-hypoxic/anoxic injury use of a magnolol and/or honokiol aromatic ring amino-substituted derivative, and a pharmaceutical composition | Oct 26, 2022 | Pending |
Array
(
[id] => 20328374
[patent_doc_number] => 12458631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Use of dihydroberberine or its derivatives for anti-glycation
[patent_app_type] => utility
[patent_app_number] => 17/973852
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 11
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/973852 | Use of dihydroberberine or its derivatives for anti-glycation | Oct 25, 2022 | Issued |
Array
(
[id] => 20142749
[patent_doc_number] => 12377064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Treatment of moderate and severe gastroparesis
[patent_app_type] => utility
[patent_app_number] => 18/047364
[patent_app_country] => US
[patent_app_date] => 2022-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6416
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047364
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047364 | Treatment of moderate and severe gastroparesis | Oct 17, 2022 | Issued |
Array
(
[id] => 19598710
[patent_doc_number] => 20240389590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => AGROCHEMICAL COMPOSITION COMPRISING A COMBINATION OF HERBICIDE ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/693991
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18693991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/693991 | AGROCHEMICAL COMPOSITION COMPRISING A COMBINATION OF HERBICIDE ACTIVE INGREDIENTS | Sep 21, 2022 | Pending |
Array
(
[id] => 18269292
[patent_doc_number] => 20230090534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/947560
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947560 | METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING COMBINATION THERAPY | Sep 18, 2022 | Pending |
Array
(
[id] => 19860680
[patent_doc_number] => 20250099466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => MILVEXIAN FOR PREVENTION AND TREATMENT OF THROMBOEMBOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/692560
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692560
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692560 | MILVEXIAN FOR PREVENTION AND TREATMENT OF THROMBOEMBOLIC DISORDERS | Sep 15, 2022 | Pending |
Array
(
[id] => 19477291
[patent_doc_number] => 20240325333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => NANO-COMPLEX COMPOSITION COMPRISING DICLOFENAC
[patent_app_type] => utility
[patent_app_number] => 18/570393
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570393
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570393 | NANO-COMPLEX COMPOSITION COMPRISING DICLOFENAC | Jun 27, 2022 | Pending |
Array
(
[id] => 18180656
[patent_doc_number] => 20230041385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => HER2 MUTATION INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/849621
[patent_app_country] => US
[patent_app_date] => 2022-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849621 | HER2 mutation inhibitors | Jun 24, 2022 | Issued |
Array
(
[id] => 19050789
[patent_doc_number] => 20240092758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/848724
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848724 | Imidazolo indazole compounds as JAK inhibitors | Jun 23, 2022 | Issued |
Array
(
[id] => 19299906
[patent_doc_number] => 20240228475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE
[patent_app_type] => utility
[patent_app_number] => 18/572342
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -87
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572342
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572342 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | Jun 16, 2022 | Pending |
Array
(
[id] => 19448828
[patent_doc_number] => 20240308958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 18/571090
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571090
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571090 | SYNTHETIC PREPARATION FOR DIROXIMEL FUMARATE | Jun 13, 2022 | Pending |
Array
(
[id] => 19360778
[patent_doc_number] => 20240262812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/570783
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570783 | N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF | Jun 9, 2022 | Pending |
Array
(
[id] => 19571829
[patent_doc_number] => 20240376121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/288504
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288504
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288504 | COMPOUNDS AND USES THEREOF | May 9, 2022 | Pending |
Array
(
[id] => 19343692
[patent_doc_number] => 20240252655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/288550
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288550
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288550 | DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS | Apr 28, 2022 | Pending |